BioSpace News Archive

Press Releases

Exact Sciences Schedules Third Quarter 2024 Earnings Call

October 8, 2024
·
1 min read
Press Releases

Caldera Medical Acquires UVision360 and the LUMINELLE Product Family, Expanding Minimally Invasive Hysteroscopy Portfolio

October 8, 2024
·
3 min read
Press Releases

NanoViricides to Present at the Global AMR Summit 2024 Tomorrow

October 8, 2024
·
9 min read
Press Releases

Merck’s KEYTRUDA® (pembrolizumab) Met Primary Endpoint of Event-Free Survival (EFS) as Perioperative Treatment Regimen in Patients With Resected, Locally Advanced Head and Neck Squamous Cell Carcinoma

October 8, 2024
·
19 min read
Press Releases

Sage Therapeutics Announces Topline Results from the Phase 2 LIGHTWAVE Study of Dalzanemdor (SAGE-718) in the Treatment of Mild Cognitive Impairment and Mild Dementia in Alzheimer’s Disease

October 8, 2024
·
5 min read
Press Releases

Mestag Therapeutics Announces License and Research Collaboration with MSD to Identify Novel Targets for Inflammatory Diseases

October 8, 2024
·
3 min read
Press Releases

Avextra Announces the Approval of NEUROBIS by the Italian Medicines Agency: A Phase II Clinical Trial Using a Proprietary Cannabis-based Medicine for the Treatment of the Symptoms of Neurodegenerative Diseases

October 8, 2024
·
4 min read
Press Releases

Teva Prolia® (Denosumab) Biosimilar Candidate is Accepted for Review by U.S. FDA and EU EMA

October 8, 2024
·
7 min read
Press Releases

Bio-Path Holdings Initiates Development of Therapeutic Program for Treatment of Obesity

October 8, 2024
·
5 min read
Press Releases

Avalo Announces First Patient Dosed in Phase 2 LOTUS Trial of AVTX-009 for the Treatment of Hidradenitis Suppurativa

October 8, 2024
·
5 min read